JORGE QUINTANA: Open Payments
NPI 1326103128 · RAHWAY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,099 in 183 payments from 18 companies in 2025. Trend: 2023 $2,688 · 2024 $2,887 · 2025 $3,099
Food & beverage: $3,091Education: $8
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 31 | $830 |
| ABBVIE INC. | 38 | $518 |
| Axsome Therapeutics, Inc. | 20 | $398 |
| Neurocrine BioSciences, Inc. | 16 | $234 |
| Almatica Pharma LLC | 13 | $185 |
| Vanda Pharmaceuticals Inc. | 18 | $183 |
| Otsuka America Pharmaceutical, Inc. | 11 | $158 |
| Alkermes, Inc. | 8 | $145 |
| Tris Pharma Inc | 5 | $82 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $69 |
Products named: CAPLYTA, VRAYLAR, Sunosi, INGREZZA, LOREEV XR, FANAPT, REXULTI, Auvelity.
Industry payments across NJ — which companies pay providers there.
